Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

about

MRI for Crohn's Disease: Present and Future

P2860

Q26785603-5E059C71-1774-450F-8024-258ED477DDA6

P2860

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

Item

http://www.wikidata.org/entity/Q38212243

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

@en

type

Item

label

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

@en

prefLabel

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

@en

P1476

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

@en

P2093

Fariba Fathi

http://www.w3.org/2001/XMLSchema#string

Fatemeh Ektefa

http://www.w3.org/2001/XMLSchema#string

Hamid Asadzadeh Aghdaie

http://www.w3.org/2001/XMLSchema#string

Mehrdad Hagh-Azali

http://www.w3.org/2001/XMLSchema#string

P2860

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Chemometrics in metabonomics.

Advantage of Applying OSC to (1)H NMR-Based Metabonomic Data of Celiac Disease

Scaling and normalization effects in NMR spectroscopic metabonomic data sets.

Metabolomics: building on a century of biochemistry to guide human health.

Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals

MR metabolomics of fecal extracts: applications in the study of bowel diseases.

Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.

MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.

Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.

P304

S19-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24834283

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4017532

http://www.w3.org/2001/XMLSchema#string

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

about

P2860

P2860

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932